REGENERON PHARMACEUTICALS INC (REGN)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for REGN
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| REGN | Director | 76 | ["Chief Executive Officer of GanD, Inc. since 2016","Chair of Grace Science, LLC since 2017","Extensive venture capital and leadership experience in the biotechnology sector and high technology","Healthcare venture capital investor","Biomedical company chief executive officer","Executive leadership experience","Substantial knowledge of the Company"] | ["Audit Committee","Compensation Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Age: 76 Director since: 1988 Board and Committee Membership 2025 Attendance Board of Directors: 14/15 Audit Committee (Chair): 9/9 Compensation Committee: 11/11 Career Highlights Chief Executive Officer of GanD, Inc. since 2016 Chair of Grace Science, LLC since 2017 Extensive venture capital and leadership experience in the biotechnology sector and high technology Experience and Expertise Industry Experience Executive/Leadership Experience Science/Biotech Background Business Strategy/ Operations Experience Financial Expertise Technology/Digital Experience Mr. Sing s extensive healthcare and financial expertise as a healthcare venture capital investor and biomedical company chief executive officer, his executive leadership experience, and his substantial knowledge of the Company led the board to conclude that Mr. Sing should serve as a director.